Cytosorbents (CTSO) Misses Q3 EPS by 9c

Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.21), $0.09 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $8.8 million versus the consensus estimate of $9.5 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
• Ameriprise Financial (AMP) Tops Q2 EPS by 29c
• Freeport-McMoran (FCX) Tops Q2 EPS by 15c